Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Hyoscine Butylbromide Versus Topical Lidocaine-Prilocaine Spray Versus Placebo for Pain Relief During Hysterosalpingography
NCT07383571Completed
- Sponsor
- Cairo University
- Start
- Oct 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, double-blind trial in procedural pain comparing Oral Hyoscine butylbromide and Placebo Spray, Topical lidocaine-prilocaine spray and placebo oral tablet and Double Placebo (3 arms). Primary endpoint: Pain during cervical instrumentation. Started Oct 2025; status: completed.
02
Drugs
hyoscine butylbromidelidocaine + prilocaine
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT07383571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07383571.